相关实验视频

Updated: Feb 25, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

克里斯普尔查重新定义了治疗目标识别和药物发现的精度和可扩展性

Yao He¹, Xiao Tu^1,2, Yuxin Xue¹

¹Laboratory of Neurological Disease Modeling and Translational Research, West China Hospital, Sichuan University, Chengdu, 610041, China.

Journal of pharmaceutical analysis

|February 24, 2026

概括

聚类正规间隔短平行体重复 (CRISPR) -Cas9查为功能基因组学和药物发现提供了一个强大的平台. 这项技术有助于识别治疗点并阐明各种疾病中的药物机制.

科学领域:

基因组学就是基因组学.
药物发现药物发现药物发现
功能性基因组学功能性基因组学

背景情况:

CRISPR-Cas9查提供了一个精确且可扩展的功能基因组学平台.
使用单导 RNA (sgRNA) 库的高通量查 (HTS) 能够系统地调查基因药物相互作用.
克里斯普尔查对于识别药物点和了解癌症和神经退行性疾病等疾病的机制至关重要.

研究的目的:

审查CRISPR查在药物发现中的原则,应用和挑战.
突出CRISPR查与人工智能和有机体等新兴技术的整合.
检查基于CRISPR的药物发现的临床翻译潜力和伦理考虑.

主要方法:

使用CRISPR-Cas9技术进行全基因组查.
开发和使用广泛的单导向RNA (sgRNA) 库,用于高通量查 (HTS).
整合CRISPR查与有机体模型,人工智能 (AI) 和大数据分析.

主要成果:

克里斯普尔查在识别各种疾病的药物标方面具有广泛的应用.
克里斯普技术和生物信息学的进步正在解决诸如非目标效应和数据复杂性等挑战.
与人工智能和有机体的整合提高了药物发现的规模,智能和自动化.

结论:

克里斯普尔查是一种在药物发现和标识中具有变革性的技术.
持续的技术和计算进步正在扩大CRISPR查的功能和应用.
将CRISPR查与其他技术相结合,有望加速新疗法的开发.

关键词:

这就是CRISPR-Cas.药物发现药物发现基因编辑基因编辑目标识别目标识别

更多相关视频

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...